-
1
-
-
0028866438
-
Early rheumatoid arthritis: Time to aim for remission?
-
Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
-
(1995)
Ann Rheum Dis
, vol.54
, pp. 944-947
-
-
Emery, P.1
Salmon, M.2
-
2
-
-
66249139579
-
Defining remission in rheumatoid arthritis: Results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference
-
Van Tuyl LH, Vlad SC, Felson DT, Wells G, Boers M. Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference. Arthritis Rheum 2009;61:704-10.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 704-710
-
-
Van Tuyl, L.H.1
Vlad, S.C.2
Felson, D.T.3
Wells, G.4
Boers, M.5
-
3
-
-
33750699312
-
What should be our treatment goal in rheumatoid arthritis today?
-
Smolen JS, Aletaha D. What should be our treatment goal in rheumatoid arthritis today? Clin Exp Rheumatol 2006;24:S-7-13. (Pubitemid 44696862)
-
(2006)
Clinical and Experimental Rheumatology
, vol.24
, Issue.6 SUPPL. 43
-
-
Smolen, J.S.1
Aletaha, D.2
-
4
-
-
0033535754
-
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
-
DOI 10.1016/S0140-6736(98)08513-4
-
Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al, for the FIN-RACo Trial Group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353: 1568-73. (Pubitemid 29219206)
-
(1999)
Lancet
, vol.353
, Issue.9164
, pp. 1568-1573
-
-
Mottonen, T.1
Hannonen, P.2
Leirisalo-Repo, M.3
Nissila, M.4
Kautiainen, H.5
Korpela, M.6
Laasonen, L.7
Julkunen, H.8
Luukkainen, R.9
Vuori, K.10
Paimela, L.11
Blafield, H.12
Hakala, M.13
Ilva, K.14
Yli-Kerttula, U.15
Puolakka, K.16
Jarvinen, P.17
Hakola, M.18
Piirainen, H.19
Ahonen, J.20
Palvimaki, I.21
Forsberg, S.22
Koota, K.23
Friman, C.24
more..
-
5
-
-
48149100741
-
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial
-
Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008;372:375-82.
-
(2008)
Lancet
, vol.372
, pp. 375-382
-
-
Emery, P.1
Breedveld, F.C.2
Hall, S.3
Durez, P.4
Chang, D.J.5
Robertson, D.6
-
6
-
-
38649098475
-
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
-
DOI 10.1002/art.23247
-
Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Saez I, Unnebrink K, Kary S, et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 2007;59:32-41. (Pubitemid 351171876)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.1
, pp. 32-41
-
-
Burmester, G.R.1
Ferraccioli, G.2
Flipo, R.-M.3
Monteagudo-Saez, I.4
Unnebrink, K.5
Kary, S.6
Kupper, H.7
-
7
-
-
35648991026
-
Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
-
DOI 10.1136/ard.2007.071092
-
Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al, for the Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9. (Pubitemid 350032650)
-
(2007)
Annals of the Rheumatic Diseases
, vol.66
, Issue.11
, pp. 1443-1449
-
-
Verstappen, S.M.M.1
Jacobs, J.W.G.2
Van Der Veen, M.J.3
Heurkens, A.H.M.4
Schenk, Y.5
Ter Borg, E.J.6
Blaauw, A.A.M.7
Bijlsma, J.W.J.8
-
8
-
-
19944431840
-
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial
-
DOI 10.1002/art.20712
-
Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:27-35. (Pubitemid 40129229)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.1
, pp. 27-35
-
-
Quinn, M.A.1
Conaghan, P.G.2
O'Connor, P.J.3
Karim, Z.4
Greenstein, A.5
Brown, A.6
Brown, C.7
Fraser, A.8
Jarret, S.9
Emery, P.10
-
9
-
-
33846001961
-
EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
-
Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld FC, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;66: 34-45.
-
(2006)
Ann Rheum Dis
, vol.66
, pp. 34-45
-
-
Combe, B.1
Landewe, R.2
Lukas, C.3
Bolosiu, H.D.4
Breedveld, F.C.5
Dougados, M.6
-
10
-
-
77950307115
-
Treating rheumatoid arthritis to target: Recommendations of an international task force
-
for the T2T Expert Committee
-
Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al, for the T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 631-637
-
-
Smolen, J.S.1
Aletaha, D.2
Bijlsma, J.W.3
Breedveld, F.C.4
Boumpas, D.5
Burmester, G.6
-
11
-
-
34247568912
-
Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort
-
DOI 10.1002/art.22619
-
Khanna D, Oh M, Furst DE, Ranganath V, Gold RH, Sharp JT, et al, for the Western Consortium of Practicing Rheumatologists. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum 2007;57:440-7. (Pubitemid 46682531)
-
(2007)
Arthritis Care and Research
, vol.57
, Issue.3
, pp. 440-447
-
-
Khanna, D.1
Oh, M.2
Furst, D.E.3
Ranganath, V.4
Gold, R.H.5
Sharp, J.T.6
Park, G.S.7
Keystone, E.C.8
Paulus, H.E.9
-
12
-
-
70350554084
-
Clinical and functional remission: Even though biologics are superior to conventional DMARDs overall success rates remain low - Results from RABBIT, the German biologics register
-
Listing J, Strangfeld A, Rau R, Kekow J, Gromnica-Ihle E, Klopsch T, et al. Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low - results from RABBIT, the German biologics register. Arthritis Res Ther 2006;8:R66.
-
(2006)
Arthritis Res Ther
, vol.8
-
-
Listing, J.1
Strangfeld, A.2
Rau, R.3
Kekow, J.4
Gromnica-Ihle, E.5
Klopsch, T.6
-
13
-
-
34447343764
-
Assessing remission in clinical practice
-
DOI 10.1093/rheumatology/kem007
-
Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS. Assessing remission in clinical practice. Rheumatology (Oxford) 2007;46:975-9. (Pubitemid 47062506)
-
(2007)
Rheumatology
, vol.46
, Issue.6
, pp. 975-979
-
-
Mierau, M.1
Schoels, M.2
Gonda, G.3
Fuchs, J.4
Aletaha, D.5
Smolen, J.S.6
-
14
-
-
51849089097
-
Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries
-
for the Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis Group
-
Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, et al, for the Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis Group. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642-51.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2642-2651
-
-
Sokka, T.1
Hetland, M.L.2
Makinen, H.3
Kautiainen, H.4
Horslev-Petersen, K.5
Luukkainen, R.K.6
-
15
-
-
2442675501
-
Prognostic factors for remission in early rheumatoid arthritis: A multiparameter prospective study
-
DOI 10.1136/ard.2003.010611
-
Gossec L, Dougados M, Goupille P, Cantagrel A, Sibilia J, Meyer O, et al. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 2004;63:675-80. (Pubitemid 38658397)
-
(2004)
Annals of the Rheumatic Diseases
, vol.63
, Issue.6
, pp. 675-680
-
-
Gossec, L.1
Dougados, M.2
Goupille, P.3
Cantagrel, A.4
Sibilia, J.5
Meyer, O.6
Sany, J.7
Daures, J.-P.8
Combe, B.9
-
16
-
-
0019407824
-
Preliminary criteria for clinical remission in rheumatoid arthritis
-
DOI 10.1002/art.1780241012
-
Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15. (Pubitemid 11022943)
-
(1981)
Arthritis and Rheumatism
, vol.24
, Issue.10
, pp. 1308-1315
-
-
Pinals, R.S.1
Masi, A.T.2
Larsen, R.A.3
-
17
-
-
0027936586
-
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
-
Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9. (Pubitemid 24285550)
-
(1994)
Journal of Rheumatology
, vol.21
, Issue.SUPPL. 41
, pp. 86-89
-
-
Boers, M.1
Tugwell, P.2
Felson, D.T.3
Van Riel, P.L.C.M.4
Kirwan, J.R.5
Edmonds, J.P.6
Smolen, J.S.7
Khaltaev, N.8
Muirden, K.D.9
-
18
-
-
5444231338
-
Remission in rheumatoid arthritis: Agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
-
DOI 10.1093/rheumatology/keh297
-
Fransen J, Creemers MC, van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004;43:1252-5. (Pubitemid 39359299)
-
(2004)
Rheumatology
, vol.43
, Issue.10
, pp. 1252-1255
-
-
Fransen, J.1
Creemers, M.C.W.2
Van Riel, P.L.C.M.3
-
19
-
-
25444481274
-
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
-
DOI 10.1002/art.21235
-
Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52: 2625-36. (Pubitemid 41369090)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.9
, pp. 2625-2636
-
-
Aletaha, D.1
Ward, M.M.2
Machold, K.P.3
Nell, V.P.K.4
Stamm, T.5
Smolen, J.S.6
-
20
-
-
0029906505
-
Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score
-
Prevoo ML, van Gestel AM, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996;35:1101-5.
-
(1996)
Br J Rheumatol
, vol.35
, pp. 1101-1105
-
-
Prevoo, M.L.1
Van Gestel, A.M.2
Van 'T Hof, M.A.3
Van Rijswijk, M.H.4
Van De Putte, L.B.5
Van Riel, P.L.6
-
21
-
-
0028815803
-
Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
-
Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 44-48
-
-
Prevoo, M.L.1
Van 'T Hof, M.A.2
Kuper, H.H.3
Van Leeuwen, M.A.4
Van De Putte, L.B.5
Van Riel, P.L.6
-
22
-
-
27444447706
-
Comparison of different definitions to classify remission and sustained remission: 1 Year TEMPO results
-
DOI 10.1136/ard.2004.034371
-
Van der Heijde D, Klareskog L, Boers M, Landewe R, Codreanu C, Bolosiu HD, et al. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis 2005;64:1582-7. (Pubitemid 41532041)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.11
, pp. 1582-1587
-
-
Van Der Heijde, D.1
Klareskog, L.2
Boers, M.3
Landewe, R.4
Codreanu, C.5
Bolosiu, H.D.6
Pedersen, R.7
Fatenejad, S.8
-
23
-
-
27744532112
-
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
-
DOI 10.1136/ard.2005.037333
-
Makinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005;64:1410-3. (Pubitemid 41623849)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.10
, pp. 1410-1413
-
-
Makinen, H.1
Kautiainen, H.2
Hannonen, P.3
Sokka, T.4
-
24
-
-
33646246737
-
Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: A comparison with the original das remission
-
Landewe R, van der Heijde D, van der Linden S, Boers M. Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission. Ann Rheum Dis 2006;65:637-41.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 637-641
-
-
Landewe, R.1
Van Der Heijde, D.2
Van Der Linden, S.3
Boers, M.4
-
25
-
-
0029044362
-
American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
-
Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 727-735
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Furst, D.5
Goldsmith, C.6
-
26
-
-
52149099504
-
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: Results from a 24-week multicentre randomised placebo-controlled trial [published erratum appears in Ann Rheum Dis 2009,68:296]
-
Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [published erratum appears in Ann Rheum Dis 2009;68:296]. Ann Rheum Dis 2008;67:1516-23.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1516-1523
-
-
Emery, P.1
Keystone, E.2
Tony, H.P.3
Cantagrel, A.4
Van Vollenhoven, R.5
Sanchez, A.6
-
27
-
-
67650379733
-
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial
-
Smolen JS, Kay J, Doyle MK, Landewe R, Matteson EL, Wollenhaupt J, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Lancet 2009; 374:210-21.
-
(2009)
Lancet
, vol.374
, pp. 210-221
-
-
Smolen, J.S.1
Kay, J.2
Doyle, M.K.3
Landewe, R.4
Matteson, E.L.5
Wollenhaupt, J.6
-
28
-
-
40749114497
-
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
-
DOI 10.1016/S0140-6736(08)60453-5, PII S0140673608604535
-
Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008;371:987-97. (Pubitemid 351392039)
-
(2008)
The Lancet
, vol.371
, Issue.9617
, pp. 987-997
-
-
Smolen, J.S.1
Beaulieu, A.2
Rubbert-Roth, A.3
Ramos-Remus, C.4
Rovensky, J.5
Alecock, E.6
Woodworth, T.7
Alten, R.8
-
29
-
-
11844263222
-
Minimal disease activity for rheumatoid arthritis: A preliminary definition
-
Wells G, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005;32:2016-24. (Pubitemid 41429036)
-
(2005)
Journal of Rheumatology
, vol.32
, Issue.10
, pp. 2016-2024
-
-
Wells, G.A.1
Boers, M.2
Shea, B.3
Brooks, P.M.4
Simon, L.S.5
Strand, C.V.6
Aletaha, D.7
Anderson, J.J.8
Bombardier, C.9
Dougados, M.10
Emery, P.11
Felson, D.T.12
Fransen, J.13
Furst, D.E.14
Hazes, J.M.W.15
Johnson, K.R.16
Kirwan, J.R.17
Landewe, R.B.M.18
Lassere, M.N.D.19
Michaud, K.20
Suarez-Almazor, M.21
Silman, A.J.22
Smolen, J.S.23
Van Der Heijde, D.M.F.M.24
Van Riel, P.L.C.M.25
Wolfe, F.26
Tugwell, P.S.27
more..
-
30
-
-
74549137918
-
Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: A systematic review
-
for the American College of Rheumatology and the European League Against Rheumatism Committee to Define Remission for Clinical Trials
-
Van Tuyl LH, Felson DT, Wells G, Smolen J, Zhang B, Boers M, for the American College of Rheumatology and the European League Against Rheumatism Committee to Define Remission for Clinical Trials. Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 2010;62:108-17.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 108-117
-
-
Van Tuyl, L.H.1
Felson, D.T.2
Wells, G.3
Smolen, J.4
Zhang, B.5
Boers, M.6
-
31
-
-
37749041179
-
OMERACT: An international initiative to improve outcome measurement in rheumatology
-
Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007;8:38.
-
(2007)
Trials
, vol.8
, pp. 38
-
-
Tugwell, P.1
Boers, M.2
Brooks, P.3
Simon, L.4
Strand, V.5
Idzerda, L.6
-
32
-
-
53149147037
-
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
-
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum 2008;59:1371-7.
-
(2008)
Arthritis Rheum
, vol.59
, pp. 1371-1377
-
-
Aletaha, D.1
Landewe, R.2
Karonitsch, T.3
Bathon, J.4
Boers, M.5
Bombardier, C.6
-
33
-
-
53149105544
-
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
-
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008;67:1360-4.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1360-1364
-
-
Aletaha, D.1
Landewe, R.2
Karonitsch, T.3
Bathon, J.4
Boers, M.5
Bombardier, C.6
-
35
-
-
34547431637
-
A proposed revision to the ACR20: The hybrid measure of American College of Rheumatology response
-
American College of Rheumatology Committee to Reevaluate Improvement Criteria
-
American College of Rheumatology Committee to Reevaluate Improvement Criteria. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response. Arthritis Rheum 2007;57:193-202.
-
(2007)
Arthritis Rheum
, vol.57
, pp. 193-202
-
-
-
36
-
-
33747879240
-
Patients and professionals as research partners: Challenges, practicalities, and benefits
-
DOI 10.1002/art.22091
-
Hewlett S, Wit M, Richards P, Quest E, Hughes R, Heiberg T, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum 2006;55:676-80. (Pubitemid 44289891)
-
(2006)
Arthritis Care and Research
, vol.55
, Issue.4
, pp. 676-680
-
-
Hewlett, S.1
De Wit, M.2
Richards, P.3
Quest, E.4
Hughes, R.5
Heiberg, T.6
Kirwan, J.7
-
37
-
-
0034735827
-
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
-
DOI 10.1056/NEJM200011303432201
-
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000; 343:1586-93. (Pubitemid 32162981)
-
(2000)
New England Journal of Medicine
, vol.343
, Issue.22
, pp. 1586-1593
-
-
Bathon, J.M.1
Martin, R.W.2
Fleischmann, R.M.3
Tesser, J.R.4
Schiff, M.H.5
Keystone, E.C.6
Genovese, M.C.7
Wasko, M.C.8
Moreland, L.W.9
Weaver, A.L.10
Markenson, J.11
Finck, B.K.12
-
38
-
-
2342658406
-
Radiographic, Clinical, and Functional Outcomes of Treatment with Adalimumab (a Human Anti-Tumor Necrosis Factor Monoclonal Antibody) in Patients with Active Rheumatoid Arthritis Receiving Concomitant Methotrexate Therapy: A Randomized, Placebo-Controlled, 52-Week Trial
-
DOI 10.1002/art.20217
-
Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004;50:1400-11. (Pubitemid 38608061)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.5
, pp. 1400-1411
-
-
Keystone, E.C.1
Kavanaugh, A.F.2
Sharp, J.T.3
Tannenbaum, H.4
Hua, Y.5
Teoh, L.S.6
Fischkoff, S.A.7
Chartash, E.K.8
-
39
-
-
0037231533
-
Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
-
DOI 10.1002/art.10697
-
Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, et al. Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45. (Pubitemid 36091645)
-
(2003)
Arthritis and Rheumatism
, vol.48
, Issue.1
, pp. 35-45
-
-
Weinblatt, M.E.1
Keystone, E.C.2
Furst, D.E.3
Moreland, L.W.4
Weisman, M.H.5
Birbara, C.A.6
Teoh, L.A.7
Fischkoff, S.A.8
Chartash, E.K.9
-
40
-
-
10744223002
-
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial
-
DOI 10.1016/S0140-6736(04)15640-7, PII S0140673604156407
-
Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al, for the TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) Study Investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81. (Pubitemid 38296553)
-
(2004)
Lancet
, vol.363
, Issue.9410
, pp. 675-681
-
-
Klareskog, L.1
Van Der Heijde, D.2
De Jager, J.P.3
Gough, A.4
Kalden, J.5
Malaise, M.6
Martin Mola, E.7
Pavelka, K.8
Sany, J.9
Settas, L.10
Wajdula, J.11
Pedersen, R.12
Fatenejad, S.13
Sanda, M.14
-
41
-
-
31044442965
-
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
-
DOI 10.1002/art.21519
-
Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al, for the PREMIER Investigators. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37. (Pubitemid 43122183)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.1
, pp. 26-37
-
-
Breedveld, F.C.1
Weisman, M.H.2
Kavanaugh, A.F.3
Cohen, S.B.4
Pavelka, K.5
Van Vollenhoven, R.6
Sharp, J.7
Perez, J.L.8
Spencer-Green, G.T.9
-
42
-
-
0036166382
-
COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
-
DOI 10.1002/art.10083
-
Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56. (Pubitemid 34136571)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.2
, pp. 347-356
-
-
Landewe, R.B.M.1
Boers, M.2
Verhoeven, A.C.3
Westhovens, R.4
Van De Laar, M.A.F.J.5
Markusse, H.M.6
Van Denderen, J.C.7
Westedt, M.L.8
Peeters, A.J.9
Dijkmans, B.A.C.10
Jacobs, P.11
Boonen, A.12
Van Der Heijde, D.M.F.M.13
Van Der Linden, S.14
-
43
-
-
77953701043
-
Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials
-
Smolen JS, Aletaha D, Grisar JC, Stamm TA, Sharp JT. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials. Ann Rheum Dis 2010;69: 1058-64.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1058-1064
-
-
Smolen, J.S.1
Aletaha, D.2
Grisar, J.C.3
Stamm, T.A.4
Sharp, J.T.5
-
44
-
-
0015151774
-
Methods of scoring the progression of radiologic changes in rheumatoid arthritis: Correlation of radiologic, clinical and laboratory abnormalities
-
Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-20.
-
(1971)
Arthritis Rheum
, vol.14
, pp. 706-720
-
-
Sharp, J.T.1
Lidsky, M.D.2
Collins, L.C.3
Moreland, J.4
-
45
-
-
0024604643
-
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
-
Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8. (Pubitemid 19123055)
-
(1989)
Lancet
, vol.1
, Issue.8646
, pp. 1036-1038
-
-
Van der Heijde, D.M.1
Van Riel, P.L.2
Nuver-Zwart, I.H.3
Gribnau, F.W.4
Van de Putte, L.B.5
-
46
-
-
0018882143
-
Measurement of patient outcome in arthritis
-
DOI 10.1002/art.1780230202
-
Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
-
(1980)
Arthritis and Rheumatism
, vol.23
, Issue.2
, pp. 137-145
-
-
Fries, J.F.1
Spitz, P.2
Kraines, R.G.3
Holman, H.R.4
-
47
-
-
1542283763
-
Radiographic Progression Depicted by Probability Plots: Presenting Data with Optimal Use of Individual Values
-
DOI 10.1002/art.20204
-
Landewe R, van der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004;50:699-706. (Pubitemid 38326167)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.3
, pp. 699-706
-
-
Landewe, R.1
Van Der Heijde, D.2
-
48
-
-
17244364098
-
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
-
DOI 10.1002/art.20982
-
Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al, for the ATTRACT Study Group. Evidence of radiographic benefit of infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy study. Arthritis Rheum 2005;52:1020-30. (Pubitemid 40530107)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.4
, pp. 1020-1030
-
-
Smolen, J.S.1
Han, C.2
Bala, M.3
Maini, R.N.4
Kalden, J.R.5
Van Der Heijde, D.6
Breedveld, F.C.7
Furst, D.E.8
Lipsky, P.E.9
-
49
-
-
67449124635
-
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: The impacts of remission and tumor necrosis factor blockade
-
for the Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group
-
Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, et al, for the Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumor necrosis factor blockade. Ann Rheum Dis 2009;68:823-7.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 823-827
-
-
Smolen, J.S.1
Han, C.2
Van Der Heijde, D.M.3
Emery, P.4
Bathon, J.M.5
Keystone, E.6
-
50
-
-
33750324355
-
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes
-
DOI 10.1002/art.22143
-
Landewe R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006;54:3119-25. (Pubitemid 44622081)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.10
, pp. 3119-3125
-
-
Landewe, R.1
Van Der Heijde, D.2
Klareskog, L.3
Van Vollenhoven, R.4
Fatenejad, S.5
-
51
-
-
0344127554
-
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
-
DOI 10.1093/rheumatology/keg072
-
Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42:244-57. (Pubitemid 36305610)
-
(2003)
Rheumatology
, vol.42
, Issue.2
, pp. 244-257
-
-
Smolen, J.S.1
Breedveld, F.C.2
Schiff, M.H.3
Kalden, J.R.4
Emery, P.5
Eberl, G.6
Van Riel, P.L.7
Tugwell, P.8
-
52
-
-
33344470277
-
The definition and measurement of disease modification in inflammatory rheumatic diseases
-
DOI 10.1016/j.rdc.2005.09.005, PII S0889857X05000724, New Therapeutic in Rheumatic Diseases
-
Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am 2006;32:9-44. (Pubitemid 43290588)
-
(2006)
Rheumatic Disease Clinics of North America
, vol.32
, Issue.1
, pp. 9-44
-
-
Aletaha, D.1
Smolen, J.S.2
-
53
-
-
34548079733
-
Remission by composite scores in rheumatoid arthritis: Are ankles and feet important?
-
Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, et al. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Arthritis Res Ther 2007;9:R72.
-
(2007)
Arthritis Res Ther
, vol.9
-
-
Kapral, T.1
Dernoschnig, F.2
MacHold, K.P.3
Stamm, T.4
Schoels, M.5
Smolen, J.S.6
-
54
-
-
76649091916
-
Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
-
Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important? J Rheumatol 2010;37:285-90.
-
(2010)
J Rheumatol
, vol.37
, pp. 285-290
-
-
Linde, L.1
Sorensen, J.2
Ostergaard, M.3
Horslev-Petersen, K.4
Hetland, M.L.5
-
55
-
-
78149471129
-
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard
-
Balsa A, de Miguel E, Castillo C, Peiteado D, Martin-Mola E. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 2010;49:683-90.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 683-690
-
-
Balsa, A.1
De Miguel, E.2
Castillo, C.3
Peiteado, D.4
Martin-Mola, E.5
-
56
-
-
0028268568
-
Reduced joint counts in controlled clinical trials in rheumatoid arthritis
-
Fuchs HA, Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994;37:470-5. (Pubitemid 24115932)
-
(1994)
Arthritis and Rheumatism
, vol.37
, Issue.4
, pp. 470-475
-
-
Fuchs, H.A.1
Pincus, T.2
-
57
-
-
0028813226
-
Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity
-
Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995;38:38-43.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 38-43
-
-
Smolen, J.S.1
Breedveld, F.C.2
Eberl, G.3
Jones, I.4
Leeming, M.5
Wylie, G.L.6
-
58
-
-
0032499141
-
Aging, health risks, and cumulative disability
-
DOI 10.1056/NEJM199804093381506
-
Vita AJ, Terry RB, Hubert HB, Fries JF. Aging, health risks, and cumulative disability. N Engl J Med 1998;338:1035-41. (Pubitemid 28180406)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.15
, pp. 1035-1041
-
-
Vita, A.J.1
Terry, R.B.2
Hubert, H.B.3
Fries, J.F.4
-
59
-
-
38749129727
-
Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: A pooled analysis of clinical trial results
-
DOI 10.1136/ard.2007.071415
-
Aletaha D, Strand V, Smolen JS, Ward MM. Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results. Ann Rheum Dis 2008;67:238-43. (Pubitemid 351183315)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.2
, pp. 238-243
-
-
Aletaha, D.1
Strand, V.2
Smolen, J.S.3
Ward, M.M.4
-
60
-
-
0022627532
-
Rheumatoid arthritis: Treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression
-
Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44-9. (Pubitemid 16156197)
-
(1986)
British Journal of Rheumatology
, vol.25
, Issue.1
, pp. 44-49
-
-
Dawes, P.T.1
Fowler, P.D.2
Clarke, S.3
-
61
-
-
0028211156
-
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants
-
Van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21: 425-9. (Pubitemid 24102824)
-
(1994)
Journal of Rheumatology
, vol.21
, Issue.3
, pp. 425-429
-
-
Van Leeuwen, M.A.1
Van der Heijde, D.M.F.M.2
Van Rijswijk, M.H.3
Houtman, P.M.4
Van Riel, P.L.C.M.5
Van de Putte, L.B.A.6
Limburg, P.C.7
-
62
-
-
0026630114
-
Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: A prospective follow-up study of 147 patients
-
Van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
-
(1992)
Br J Rheumatol
, vol.31
, pp. 519-525
-
-
Van Der Heijde, D.M.1
Van Riel, P.L.2
Van Leeuwen, M.A.3
Van'T Hof, M.A.4
Van Rijswijk, M.H.5
Van De Putte, L.B.6
-
63
-
-
34547535149
-
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ)
-
DOI 10.1016/j.berh.2007.02.009, PII S1521694207000307
-
Pincus T, Yazici Y, Bergman M, Maclean R, Harrington T. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative Routine Assessment of Patient Index Data (RAPID) scores on a Multidimensional Health Assessment Questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 2007;21:789-804. (Pubitemid 47177167)
-
(2007)
Best Practice and Research in Clinical Rheumatology
, vol.21
, Issue.4
, pp. 789-804
-
-
Pincus, T.1
Yazici, Y.2
Bergman, M.3
Maclean, R.4
Harrington, T.5
-
64
-
-
33750979015
-
An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis
-
Pincus T, Chung C, Segurado OG, Amara I, Koch GG. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006;33: 2146-52. (Pubitemid 44749771)
-
(2006)
Journal of Rheumatology
, vol.33
, Issue.11
, pp. 2146-2152
-
-
Pincus, T.1
Chung, C.2
Segurado, O.G.3
Amara, I.4
Koch, G.G.5
-
65
-
-
34248650927
-
Patient perspective: Reasons and methods for measuring fatigue in rheumatoid arthritis
-
Kirwan JR, Hewlett S. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol 2007; 34:1171-3. (Pubitemid 46774869)
-
(2007)
Journal of Rheumatology
, vol.34
, Issue.5
, pp. 1171-1173
-
-
Kirwan, J.R.1
Hewlett, S.2
-
66
-
-
33845608765
-
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: Evidence from an imaging study may explain structural progression
-
DOI 10.1002/art.22190
-
Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006;54: 3761-73. (Pubitemid 44955876)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.12
, pp. 3761-3773
-
-
Brown, A.K.1
Quinn, M.A.2
Karim, Z.3
Conaghan, P.G.4
Peterfy, C.G.5
Hensor, E.6
Wakefield, R.J.7
O'Connor, P.J.8
Emery, P.9
-
67
-
-
54949135724
-
An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis
-
Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008;58:2958-67.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2958-2967
-
-
Brown, A.K.1
Conaghan, P.G.2
Karim, Z.3
Quinn, M.A.4
Ikeda, K.5
Peterfy, C.G.6
-
68
-
-
0030749194
-
Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
-
Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85. (Pubitemid 27320685)
-
(1997)
Journal of Rheumatology
, vol.24
, Issue.8
, pp. 1477-1485
-
-
Wolfe, F.1
|